A few days after the film’s premiere, I had lunch with Squibb in her hotel room, and we talked about the movie, her ...

The novel PDE10A inhibitor CPL’36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

Bristol Myers Squibb is storming ASCO 2025 with data from over 80 studies covering 20+ cancer types, showcasing its oncology ...

ZoomRx polled 50 experienced oncologists and hemato-oncologists about 20 cancer drugmakers, asking the doctors to rank the ...

The Food and Drug Administration (FDA) has approved the combination of nivolumab (Opdivo ®) plus ipilimumab (Yervoy ® ), both from Bristol Myers Squibb Company, as an option for first-line therapy for ...

Let’s dig into the relative performance of Corcept (NASDAQ:CORT) and its peers as we unravel the now-completed Q1 branded ...

Bristol Myers Squibb is gearing up for its moment in the spotlight at the Bernstein 41st Annual Strategic Decisions ...

BMSCH opens a Same Day Services center for kids needing infusion therapies, backed by a $2.5M gift from the Bristol Myers ...

The stock's fall snapped a four-day winning streak.

MIT researchers found a way to measure cell density quickly and accurately -- measuring up to 30,000 cells in a single hour.

We recently published an article titled 13 Best Multibagger Stocks to Invest in Now. Perspective Therapeutics, Inc.

Roche, along with Bristol Myers Squibb, Novo Nordisk, AbbVie, Eli Lilly and others, is making inroads into molecular glues to ...